Comparison of expression patterns of keratin 6, 7, 16, 17, and 19 within multiple independent isolates of As +3- and Cd +2-induced bladder cancer: Keratin 6, 7, 16, 17, and 19 in bladder cancer

Cell Biology and Toxicology

Volumn 27, Issue 6, 2011, Pages 381-396

  Somji, Seema ^a   Cao, Ling ^a   Mehus, Aaron ^a   Zhou, Xu Dong ^a   Sens, Mary Ann ^a   Dunlevy, Jane R ^a   Garrett, Scott H ^a   Zheng, Yun ^a   Larson, Jennifer L ^a   Sens, Donald A ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Arsenic; Bladder cancer; Cadmium; Keratin; Urothelial cancer; UROtsa

Indexed keywords

ARSENIC; CADMIUM; CYTOKERATIN 16; CYTOKERATIN 17; CYTOKERATIN 19; CYTOKERATIN 6; CYTOKERATIN 7; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER CELL CULTURE; CELL TRANSFORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PERITONEUM TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SUBCUTANEOUS TISSUE TUMOR; TRANSITIONAL CELL CARCINOMA; TUMOR DIFFERENTIATION;

ANIMALS; ARSENITES; BLOTTING, WESTERN; CADMIUM; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 82455179426     PISSN: 07422091     EISSN: 15736822     Source Type: Journal    
DOI: 10.1007/s10565-010-9169-z     Document Type: Article

References (27)

1. Aaboe M, Marcussen N, Jensen KM, Thykjaer T, Dyrsjot L, Orntoft TF. Gene expression profiling of noninvasive primary urothelial tumors using microarrays. Br J Cancer. 2005;14;93(10):1182-90. (Pubitemid 41670704)
2. A Akdas L Turkeri 1990 The impact of squamous metaplasia in transitional cell carcinoma of the bladder Int J Urol Nephrol 23 333 6 10.1007/BF02549603
3. A Alonso U Ikinger J Kartenbeck 2009 Staining patterns of keratins in the human urinary tract Histol Histopathol 24 1425 37 19760592 1:CAS:528: DC%2BD1MXhsVCktbvK
4. CJ Bischoff PE Clark 2009 Bladder cancer Curr Opin Oncol 21 272 7 19370808 10.1097/CCO.0b013e328329f184 1:CAS:528:DC%2BD1MXktl2ju74%3D
5. KP Cantor JH Lubin 2007 Arsenic, internal cancers, and issues in inference from studies at low-level exposures in human populations Toxicol Appl Pharmacol 222 252 7 17382983 10.1016/j.taap.2007.01.026 1:CAS:528: DC%2BD2sXovFKqurg%3D (Pubitemid 47214560)
6. (+)3-induced bladder cancer. J Appl Toxicol. 2010;30(5):416-30.
7. HY Chiou Y Hsueh KF Liaw SF Hong MH Chiang YS Pu JS Lin CH Huang CJ Chen 1995 Incidence of internal cancers and ingested inorganic arsenic: a 7-year follow-up study in Taiwan Cancer Res 55 1296 300 7882325 1:CAS:528: DyaK2MXktlKmtrY%3D
8. P Chu LM Weiss 2002 Keratin expression in human tissues and neoplasms Histopathology 40 403 39 12010363 10.1046/j.1365-2559.2002.01387.x 1:STN:280:DC%2BD383ntFOrtA%3D%3D (Pubitemid 34535443)
9. P Chu E Wu LM Weiss 2000 Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases Mod Pathol 13 962 72 11007036 10.1038/modpathol.3880175 1:STN:280:DC%2BD3cvltFenug%3D%3D
10. HA Frazier JE Robertson RK Dodge DF Paulson 1993 The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate Cancer 71 3993 4001 8508365 10.1002/1097-0142(19930615)71:12<3993::AID- CNCR2820711233>3.0.CO;2-Y 1:STN:280:DyaK3s3osVGiug%3D%3D (Pubitemid 23172983)
11. J Jiang TM Ulbright C Younger K Sanchez D Bostwick MO Kock JN Eble L Cheng 2001 Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis Arch Pathol Lab Med 125 921 3 11419977 1:STN:280:DC%2BD3MzlvFCrug%3D%3D (Pubitemid 32623190)
12. E Kellen M Zeegers ED Hond F Buntinx 2007 Blood cadmium may be associated with bladder carcinogenesis; the Belgian case control study on bladder cancer Cancer Detect Prev 31 77 82 17296271 10.1016/j.cdp.2006.12.001 1:CAS:528:DC%2BD2sXltFKmsLw%3D (Pubitemid 46367448)
13. CJ Logothetis FH Dexeus C Chong A Sella AG Ayala JY Ro S Pilat 1989 Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the MD Anderson experience J Urol 141 33 7 2908950 1:STN:280:DyaL1M%2FmvV2iug%3D%3D (Pubitemid 19028818)
14. MI Luster PP Simeonova 2004 Arsenic and urinary bladder cell proliferation Toxicol Appl Pharmacol 198 419 23 15276422 10.1016/j.taap.2003.07. 017 1:CAS:528:DC%2BD2cXmtVaiu7Y%3D (Pubitemid 38969971)
15. JE Martin BJ Jenkins RJ Zuk JP Blandy SI Baithun 1989 Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder J Clin Pathol 42 250 3 2703540 10.1136/jcp.42.3.250 1:STN:280: DyaL1M7pvVWgtA%3D%3D (Pubitemid 19077266)
16. R Moll M Divo L Langhein 2008 The human keratins: biology and pathology Histochem Cell Biol 129 705 33 18461349 10.1007/s00418-008-0435-6 1:CAS:528:DC%2BD1cXlvFajt78%3D
17. MR Rossi JRW Masters S Park JH Todd SH Garrett MA Sens S Somji J Nath DA Sens 2001 The immortalized UROtsa cell line as a potential cell culture model of human urothelium Environ Health Perspect 109 801 8 11564615 10.1289/ehp.01109801 1:CAS:528:DC%2BD3MXntFamtr8%3D (Pubitemid 32910302)
18. S Satarug SH Garrett MA Sens DA Sens 2010 Cadmium, environmental exposure and health outcomes Environ Health Perspect 118 182 90 20123617 10.1289/ehp.0901234 1:CAS:528:DC%2BC3cXis1WgurY%3D
19. S Satarug MR Moore 2004 Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke Environ Health Perspect 112 1099 103 15238284 10.1289/ehp.6751 1:CAS:528:DC%2BD2cXps1agsbg%3D (Pubitemid 39029166)
20. Sens DA, Park S, Gurel V, Sens MA, Garrett SH, Somji S. Inorganic cadmium-and arsenit-induced malignant transformation of human bladder urothelial cells. Toxicol Sci. 2004;79(1):56-63. (Pubitemid 38660248)
21. J Siemiatycki R Dewar L Nadon M Gerin 1994 Occupational risk factors for bladder cancer: Results from a case control study in Montreal, Quebec, Canada. Am J Epidemiol 140 1061 80 7998589 1:STN:280:DyaK2M%2FptFagtA%3D%3D
22. AH Smith M Goycolea R Haque ML Biggs 1998 Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water Am J Epidemiol 147 660 9 9554605 1:STN:280:DyaK1c3htlehtA%3D%3D (Pubitemid 28180309)
23. S Somji XD Zhou A Mehus MA Sens SH Garrett KL Lutz JR Dunlevy Y Zheng DA Sens 2010 Variation of keratin 7 expression and other phenotypic characteristics of independent isolates of cadmium transformed human urothelial cells (UROtsa) Chem Res Toxicol 23 348 56 19921857 10.1021/tx900346q 1:CAS:528: DC%2BD1MXhsVensrbJ
24. C Steinmaus L Moore C Hopenhayn-Rich ML Biggs AH Smith 2000 Arsenic in drinking water and bladder cancer Cancer Invest 18 174 82 10705880 10.3109/07357900009038249 1:CAS:528:DC%2BD3cXhvF2kurc%3D (Pubitemid 30118411)
25. T Tsuda A Babazono E Yamamoto N Kurumatini Y Mino T Ogawa Y Kishi H Aoyama 1995 Ingested arsenic and internal cancer: a historical cohort study followed for 33 years Am J Epidemiol 141 198 209 7840093 1:STN:280: DyaK2M7kt1SltA%3D%3D
26. MP Waalkes 2000 Cadmium carcinogenesis in review J Inorg Biochem 79 241 4 10830873 10.1016/S0162-0134(00)00009-X 1:CAS:528:DC%2BD3cXjslyrsLc%3D (Pubitemid 30628738)
27. NP Wang S Zee RJ Zarbo 1995 Coordinate expression of cytokeratin 7 and 20 defines unique subsets of carcinomas Appl Immunohistochem 51 219 23